Novartis AG

Open: 103.09 Close: 103.04 Change: -0.05

The best way to get informed about Novartis AG Company Inc Stock without reading hundreds of pages.

Are looking for the most relevant information about Novartis AG? Investor spend a lot of time searching for information to make investment decisions in Novartis AG. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: Novartis, AG, company, year, Novartes, medicine, average, and the most common words in the summary are: novartis, stock, market, ag, price, news, pharmaceutical, . One of the sentences in the summary was: Novarti will post 6.66 EPS for the current year.. Other searches …

Concept Map

Semantic Network

Stock Summary

Novartis AG researches, develops, manufactures, markets, markets healthcare products. The company operates through two segments: Innovative Medicines and Sandoz. Novarti has a license and collaboration agreement with Alnylam Pharmaceuticals.

Today's Summary

Novartis AG makes up about 2.8% of John G Ullman & Associates investment portfolio and continues to be their ninth largest position. Novarti will post 6.66 EPS for the current year.

Today's News

Novartis AGs revenue was $51.83 billion, a decrease of -1.98% compared to the previous years $52.88 billion. Novartes CEO Vas Narasimhan: Our medicines are starting to take market share. Novartis AG (NYSE: NVS) has an average rating of “Hold” and a consensus price target of $82.25. The Swiss pharmaceutical giant has a twelve month low of $74.09 and a twelve months high of $105.56. On average, research analysts forecast that Novarti will post 6.66 EPS for the current year. Novartis AG makes up about 2.8% of John G Ullman & Associates Inc.s investment portfolio and continues to be their ninth largest position. John G.Ullman and Associates cut its stake in Novartes AG (NYSE:NVS) by 1.9% during the fourth quarter. Novartis Pharmaceuticals Indianapolis, Indiana AAA StatementAdvanced Accelerator Applications is an innovative medicines company. Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. The company was incorporated in 1996.

Stock Profile

"Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland."

Keywords

This document will help you to evaluate Novartis AG without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: Novartis, AG, company, year, Novartes, medicine, average, and the most common words in the summary are: novartis, stock, market, ag, price, news, pharmaceutical, . One of the sentences in the summary was: Novarti will post 6.66 EPS for the current year.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #novartis #stock #market #ag #price #news #pharmaceutical.